Nicole Erin Kinsey White

Array ( [id] => 10406938 [patent_doc_number] => 20150291948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-15 [patent_title] => 'NUCLEIC ACIDS USEFUL FOR INTEGRATING INTO AND GENE EXPRESSION IN HYPERTHERMOPHILIC ACIDOPHILIC ARCHAEA' [patent_app_type] => utility [patent_app_number] => 14/646673 [patent_app_country] => US [patent_app_date] => 2013-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12966 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14646673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9338399 [patent_doc_number] => 20140065181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-06 [patent_title] => 'GENETICALLY STABLE RECOMBINANT MODIFIED VACCINIA ANKARA (RMVA) VACCINES AND METHODS OF PREPARATION THEREOF' [patent_app_type] => utility [patent_app_number] => 14/075975 [patent_app_country] => US [patent_app_date] => 2013-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 28230 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14075975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11183703 [patent_doc_number] => 09415089 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-16 [patent_title] => 'Methods of treating virally-infected living cells with histones' [patent_app_type] => utility [patent_app_number] => 14/074585 [patent_app_country] => US [patent_app_date] => 2013-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 3142 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14074585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10383240 [patent_doc_number] => 20150268247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-24 [patent_title] => 'Assay for Screening of Anti-Viral Compounds That Inhibit Specific Interaction Interfaces Between Cullin5 and an ElonginB/ElonginC/ CBF-beta/HIV-1 Vif Complex' [patent_app_type] => utility [patent_app_number] => 14/435860 [patent_app_country] => US [patent_app_date] => 2013-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 33458 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14435860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9737441 [patent_doc_number] => 20140273159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-18 [patent_title] => 'Staged Bacteriophage Remediation of Target Bacteria' [patent_app_type] => utility [patent_app_number] => 14/056808 [patent_app_country] => US [patent_app_date] => 2013-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2906 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14056808 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9421216 [patent_doc_number] => 20140105866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-17 [patent_title] => 'BACTERIOPHAGES USEFUL FOR THE PROPHYLAXIS AND THERAPY OF VIBRIO ANGUILLARUM' [patent_app_type] => utility [patent_app_number] => 14/055279 [patent_app_country] => US [patent_app_date] => 2013-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6483 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14055279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9294048 [patent_doc_number] => 20140037682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-06 [patent_title] => 'HIV/SIV VACCINES FOR THE GENERATION OF MUCOSAL AND SYSTEMIC IMMUNITY' [patent_app_type] => utility [patent_app_number] => 14/052309 [patent_app_country] => US [patent_app_date] => 2013-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 28126 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14052309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10388028 [patent_doc_number] => 20150273035 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-01 [patent_title] => 'VACCINATION AGAINST JAPANESE ENCEPHALITIS, MEASLES, MUMPS AND RUBELLA' [patent_app_type] => utility [patent_app_number] => 14/433256 [patent_app_country] => US [patent_app_date] => 2013-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6093 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14433256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10353575 [patent_doc_number] => 20150238580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-27 [patent_title] => 'GLYCOSIDASE REGIMEN FOR TREATMENT OF INFECTIOUS DISEASE' [patent_app_type] => utility [patent_app_number] => 14/431249 [patent_app_country] => US [patent_app_date] => 2013-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10105 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14431249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10354956 [patent_doc_number] => 20150239961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-27 [patent_title] => 'ADCC-MEDIATING ANTIBODIES, COMBINATIONS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/431537 [patent_app_country] => US [patent_app_date] => 2013-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 21461 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14431537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11843462 [patent_doc_number] => 09731002 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-15 [patent_title] => 'HIV-1 GP 120 V1/V2 antigens and immunological uses thereof' [patent_app_type] => utility [patent_app_number] => 14/427393 [patent_app_country] => US [patent_app_date] => 2013-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 58 [patent_no_of_words] => 8181 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14427393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10470162 [patent_doc_number] => 20150355178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-10 [patent_title] => 'SYSTEM AND METHOD FOR IMPROVING BIOMARKER ASSAY' [patent_app_type] => utility [patent_app_number] => 14/425408 [patent_app_country] => US [patent_app_date] => 2013-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12878 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14425408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9307069 [patent_doc_number] => 20140045743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-13 [patent_title] => 'COMPOSITIONS AND METHODS FOR CORONAVIRUS INHIBITION' [patent_app_type] => utility [patent_app_number] => 13/962524 [patent_app_country] => US [patent_app_date] => 2013-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11305 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13962524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9937605 [patent_doc_number] => 08987416 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-24 [patent_title] => 'Viral fusion protein treatment for CCR8 mediated diseases' [patent_app_type] => utility [patent_app_number] => 13/962757 [patent_app_country] => US [patent_app_date] => 2013-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12456 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13962757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12924766 [patent_doc_number] => 09827302 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-11-28 [patent_title] => HPV/CyaA-based chimeric proteins and their uses in the induction of immune responses against HPV infection and HPV-induced disorders [patent_app_type] => utility [patent_app_number] => 14/416384 [patent_app_country] => US [patent_app_date] => 2013-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 17 [patent_no_of_words] => 29562 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14416384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9792744 [patent_doc_number] => 20150004688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-01 [patent_title] => 'Processes for Packaging Oligonucleotides Into Virus-Like Particles of RNA Bacteriophages' [patent_app_type] => utility [patent_app_number] => 13/945708 [patent_app_country] => US [patent_app_date] => 2013-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18686 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13945708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11794372 [patent_doc_number] => 09404126 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-02 [patent_title] => 'Processes for packaging aggregated oligonucleotides into virus-like particles of RNA bacteriophages' [patent_app_type] => utility [patent_app_number] => 13/942483 [patent_app_country] => US [patent_app_date] => 2013-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 18795 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 451 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13942483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10306700 [patent_doc_number] => 20150191702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-09 [patent_title] => 'Paramyxovirus and Methods of Use' [patent_app_type] => utility [patent_app_number] => 14/412533 [patent_app_country] => US [patent_app_date] => 2013-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 19094 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14412533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9205378 [patent_doc_number] => 20140004555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-02 [patent_title] => 'Non-Transformed, Immortalized Human T-Lymphocyte Cell-Lines' [patent_app_type] => utility [patent_app_number] => 13/929328 [patent_app_country] => US [patent_app_date] => 2013-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5387 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13929328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10290666 [patent_doc_number] => 20150175666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-25 [patent_title] => 'PEPTIDES DERIVED FROM HIV GP41 FOR TREATING T-CELL MEDIATED PATHOLOGIES' [patent_app_type] => utility [patent_app_number] => 14/408950 [patent_app_country] => US [patent_app_date] => 2013-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17916 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14408950 [rel_patent_id] =>[rel_patent_doc_number] =>)